Skip to content
DraconiticResearch
Search Sources API
211,646 studies31 sourcesUpdated 59 min ago

Oncology

5,331 studies510 in 7 days2,567 in 30 days

Filters
Type
Date
Clear

Latest

5,331 studies

  1. Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinoma
    Emeline Guiard, Florian Clatot, Caroline Even +5
    European Journal of CancerPeer-reviewedPublisher termsFull text20 citedOncologyHAL
  2. NMR spectroscopy stability studies of Ru-IM, a prodrug candidate for triple negative breast cancer
    Marayke Mayrata, Alvaro Lopez-Sanchez, Esteban Urriolabeitia +5
    Journal of Inorganic BiochemistryPeer-reviewedLicence not stated1 citedOncologyHAL
  3. Colorectal Cancer at the Crossroads: The Good, the Bad, and the Future of Platinum-Based Drugs
    Jia Xuan Kee, Jia Ning Nicolette Yau, Ram Pravin Kumar Muthuramalingam +10
    Chemical ReviewsPeer-reviewedCC BY-NC-ND 4.0Full text25 citedOncologyHAL
  4. Zosuquidar restores drug sensitivity in P-glycoprotein expressing acute myeloid leukemia (AML)
    Ruoping Tang, Anne-Marie Faussat, Jean-Yves Perrot +6
    BMC CancerPeer-reviewedCC BY 4.0Full text66 citedOncologyPharmacology & toxicologyHAL
  5. PP2A Cdc55 Phosphatase Imposes Ordered Cell-Cycle Phosphorylation by Opposing Threonine Phosphorylation
    Molly Godfrey, Sandra Touati, Meghna Kataria +3
    Molecular CellPeer-reviewedCC BYFull text105 citedOncologyHAL
  6. Lorlatinib in frontline treatment of advanced ALK-positive non-small cell lung cancer: a highly efficient new standard of care but still challenging to manage
    Mylène Wespiser, Aurélie Swalduz, Maurice Pérol
    Translational Lung Cancer ResearchPeer-reviewedCC BY-NC-NDOncologyHAL
  7. Uveal melanoma: In the era of new treatments
    Wespiser Mylène, E. Neidhardt, S. Negrier
    Cancer Treatment ReviewsPeer-reviewedLicence not stated55 citedOncologyHAL
  8. Combined prognostic value of age at onset and socioeconomic status for long-term survival in metastatic breast cancer
    Ke Zhou, Germán Cano-Sancho, Caroline Goupille +5
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyHAL
  9. Treatment sequences in EGFR mutant advanced NSCLC
    Wespiser Mylène, A. Swalduz, M. Pérol
    Lung CancerPeer-reviewedLicence not statedFull text16 citedOncologyHAL
  10. Colonic Metastases from Lung Adenocarcinoma Detected During an Evaluation of Recurrent Diarrhea Associated with Immune-Related Colitis
    Naohito Hashimoto, Yoshiaki Nagai, Konjo Cho +7
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  11. Neutrophil-to-lymphocyte Ratio as a Prognostic Indicator in Patients with Nursing and Healthcare-associated Pneumonia: A Retrospective Study
    Yuki Hiraoka, Takashi Ogasawara, Ei Kishimoto +6
    Internal MedicinePeer-reviewedCC BY-NC-NDFull text1 citedOncologyJ-STAGE
  12. Management of diarrhea in patients receiving liposomal irinotecan-based regimens: a narrative review of mechanisms, clinical impact, and evidence-based strategies.
    Alberto Zaniboni
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  13. Pt(iv) scaffold effects on nucleolar stress and DNA damage response pathways
    Christopher R. Griffin, Victoria J. DeRose
    RSC Chemical BiologyPeer-reviewedCC BY-NC 3.0Full textOncologyPMC
  14. First-line fecal microbiota transplantation for the management of immune checkpoint inhibitor-mediated diarrhea and colitis
    Yinghong Wang, Christopher Fan, Krishnavathana Varatharajalu +29
    Cell Reports MedicinePeer-reviewedCC BY-NC-ND 4.0Full text1 citedOncologyPMC
  15. XPO1 Inhibition by Selinexor Induces Nuclear p53 and p21 Accumulation, Cell-Cycle Arrest and Apoptosis in Testicular Germ Cell Tumors
    R. Islam, A. Wladhaus, I. Bollen +8
    bioRxivPreprintCC BY-NDFull textOncologybioRxiv
  16. A Hybrid Residual-Swin Transformer Design with Attention for Prostate Cancer Segmentation
    R. Singh, S. Gupta, S. Juneja +4
    bioRxivPreprintCC BYFull textOncologybioRxiv
  17. Clustered structural variant hotspots enable oncogenic addiction and plasticity in osteosarcoma
    S. Raman, T. Kaltenbacher, D. Merrell +27
    bioRxivPreprintCC BYFull textOncologybioRxiv
  18. MetScore and classical-basal subtype intersect to define chemotherapy response and tumor microenvironment architecture in pancreatic ductal adenocarcinoma
    R. E. Preston, H. Huang, M. A. Hall +7
    bioRxivPreprintCC BY-NCFull textOncologybioRxiv
  19. Cardiomyocytes upregulated PD-L1 expression to alleviate cardiac injury induced by irradiation combined with anti-PD-1 antibody: an in vitro and in vivo study
    Y. Zhou, Y. Wu, N. Zhang +5
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv
  20. Gap Junction Protein Connexin43 (Cx43) Promotes Glioma Invasion via the Annexin A2/MMP3 Signaling Axis
    C. Glufka, E. Ojefua, L. J. Foster +3
    bioRxivPreprintCC BYFull textOncologybioRxiv
  21. Risk-Window Palbociclib Exposure Delays ErbB2-Driven Mammary Tumorigenesis and Suppresses Mammary Epithelial Cell Stemness
    Y. Liu, A. B. Parris, Z. Ma +3
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  22. Comparative Genomic and Epigenetic Landscape of Histone H3.3 G34R and K27M-Mutated Pediatric High-Grade Glioma Suggests Divergent Precision Oncology Strategies
    Z. Islam, L. Zhou, W. S. El-Deiry
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  23. Metabolic Targeting of SREBP1 Reprograms the Obesity-Driven Ascites Immune Microenvironment and Enhances Chemotherapy Response in Obesity-Associated Ovarian Cancer
    J. Yang, T. S. HILLIARD, Y. LIU +12
    bioRxivPreprintCC BYFull textOncologybioRxiv
  24. Targeting Tumor Immunity: Statins as a Repurposed Strategy for Preventing Ovarian Cancer Advancement
    J. M. Liberto, S. Qi, M. M. Rana +2
    bioRxivPreprintCC BY-NC-NDFull textOncologybioRxiv
  25. Dynamics of circulating tumor cell subsets defined by PSMA and EpCAM predict survival in metastatic castration-resistant prostate cancer patients treated with 177Lu-PSMA-617
    M. J. Lee, L. Yu, N. Zorko +5
    bioRxivPreprintCC BYFull textOncologybioRxiv